Moteur de recherche d’entreprises européennes
Financement de l’UE (4 023 721 €) : RÉGULATION MÉTABOLIQUE DE LA FONCTION DU GÉNOME ET DE L’IDENTITÉ CELLULAIRE Hor04/07/2024 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
RÉGULATION MÉTABOLIQUE DE LA FONCTION DU GÉNOME ET DE L’IDENTITÉ CELLULAIRE
NUCLEAR aims at educating future experts that can drive the emerging field of Metabolic Regulation of Genome Function and Cell Identity relevant for stem cell biology and cancer. It is a Doctoral Training Network composed of 14 beneficiaries and 12 partner organisations including three industrial partners, a training-oriented foundation, a patient support association from 8 EU member states, 1 associated country and a non-EU member state self-funding itself to the level of beneficiary. Given the highly interdisciplinary nature of this emerging field, no single institution can provide all suitable infrastructures and the know-how required for high-quality PhD-level training. To address this shortfall in training capacity, NUCLEAR brings together European leaders in metabolomics, functional genomics, chromatin regulation, stem cell biology and cancer with innovators in precision nutrition, mass spectrometry technologies and drug development. Together we are committed to the following: 1. To train 16 doctoral candidates (DCs) through an innovative program structured in four capacity axes and occurring on three complementary levels to deliver enabling scientific and transferable skills. 2. To guide DCs in collaborative research bridging boundaries of countries, sectors, and disciplines. 3. To address three key challenges that limit the advancement and exploitation of the field and that are the lack of tools to measure nuclear metabolism, the lack of understanding of underlying molecular mechanisms and the lack of targets for novel cancer therapies. 4. To build lasting infrastructures for dissemination, communication and exploitation promoting an entrepreneurial culture and maximizing and extending the impact of this proposal beyond its lifetime. 5. To increase the international visibility of European research by taking leadership in the emerging field of Metabolic Regulation of Genome Functions and Cell Identity.
| Asociación Española Contra El Cáncer | ? |
| EISBACH BIO GmbH | 260 539 € |
| Fundacio Centre de Regulacio Genomica | 251 971 € |
| Fundacio Institut de Recerca Contra La Leucemia Josep Carreras | 503 942 € |
| Karolinska Institutet | 293 710 € |
| Kobenhavns Universitet | 301 788 € |
| LEIBNIZ-INSTITUT FUR ANALYTISCHE WISSENSCHAFTEN-ISAS-e. V. | 260 539 € |
| MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) | 0,00 € |
| Precision Forhealth SL | 251 971 € |
| STICHTING RADBOUD UNIVERSITEIT | 274 370 € |
| Stockholms Universitet | 260 504 € |
| Universita Degli Studi Di Milano | 259 438 € |
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | 274 370 € |
| Universitetet I Bergen | 297 749 € |
| Universitetet I Tromsoe - Norges Arktiske Universitet | 297 749 € |
| University of Cyprus | 235 080 € |
https://cordis.europa.eu/project/id/101166838
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Asociacion Española Contra El Cancer, Madrid, Espagne.